DiaMedica anticipates top line data for Part 1A in the first half of 2025 which is expected to demonstrate initial proof-of-concept including whether DM199 is safe and lowers blood pressure.

While medical headlines often focus on the biochemical underpinnings of disease, our body's biomechanics are equally crucial.

A simple biomaterial-based strategy that can influence the behavior of cells could pave the way for more effective medical ...

Ongoing fundamental research on cancer cells could be used to create new drugs and therapies that fight the spread of cancer ...

The ability of the bone marrow to produce healthy blood cells declines significantly with age, leading to age-related ...

BostonGene has secured top honors in five categories in the 2024 Pharmaceutical Excellence Awards – Business Expansion, ...

The global nucleic acid amplification testing market revenue was around US$ 4.8 billion in 2022 and is estimated to reach US$ 9.1 billion by 2032, growing at a compound annual growth rate (CAGR) of ...

At Durban's King Dinuzulu Hospital, a TB patient with advanced lung disease awaits surgery for massive haemoptysis - severe ...

RIYADH, Saudi Arabia, Nov. 10, 2024 (GLOBE NEWSWIRE) -- (KFSHRC) announced a significant advancement in stem cell science, ...

This important manuscript provides insights into the competition between Splicing Factor 1 (SF1) and Quaking (QKI) for binding at the ACUAA branch point sequence in a model intron, regulating exon ...

The hymen is a thin membrane of tissue located at the opening of the vagina. It varies widely in shape, size, thickness, and ...